MIRA INFORM REPORT

 

 

Report Date :

31.05.2013

 

IDENTIFICATION DETAILS

 

Name :

MEDICON HELLAS S.A.

 

 

Registered Office :

5-7 Melitona  15344 Gerakas Attiki                                                                                                    

 

 

Country :

Greece  

 

 

Financials (as on) :

31.12.2012

 

 

Date of Incorporation :

01.01.1988

 

 

Com. Reg. No.:

016439

 

 

Legal Form :

Societe anonyme

 

 

Line of Business :

Wholesales of drugs, proprietaries, and sundries

 

 

No. of Employees :

74

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

Payment Behaviour :

No Complaints

Litigation :

Clear

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March, 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

Greece  

B2

B2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 


 

GREECE -  ECONOMIC OVERVIEW

 

Greece has a capitalist economy with a public sector accounting for about 40% of GDP and with per capita GDP about two-thirds that of the leading euro-zone economies. Tourism provides 15% of GDP. Immigrants make up nearly one-fifth of the work force, mainly in agricultural and unskilled jobs. Greece is a major beneficiary of EU aid, equal to about 3.3% of annual GDP. The Greek economy grew by nearly 4% per year between 2003 and 2007, due partly to infrastructural spending related to the 2004 Athens Olympic Games, and in part to an increased availability of credit, which has sustained record levels of consumer spending. But the economy went into recession in 2009 as a result of the world financial crisis, tightening credit conditions, and Athens' failure to address a growing budget deficit. The economy contracted by 2.3% in 2009, 3.5% in 2010, 6.9% in 2011, and 6.0% in 2012. Greece violated the EU's Growth and Stability Pact budget deficit criterion of no more than 3% of GDP from 2001 to 2006, but finally met that criterion in 2007-08, before exceeding it again in 2009, with the deficit reaching 15% of GDP. Austerity measures reduced the deficit to about 8% in 2012. Deteriorating public finances, inaccurate and misreported statistics, and consistent underperformance on reforms prompted major credit rating agencies to downgrade Greece's international debt rating in late 2009, and has led the country into a financial crisis. Under intense pressure from the EU and international market participants, the government adopted a medium-term austerity program that includes cutting government spending, decreasing tax evasion, overhauling the health-care and pension systems, and reforming the labor and product markets. Athens, however, faces long-term challenges to push through unpopular reforms in the face of widespread unrest from the country's powerful labor unions and the general public. In April 2010 a leading credit agency assigned Greek debt its lowest possible credit rating; in May 2010, the International Monetary Fund and Euro-Zone governments provided Greece emergency short- and medium-term loans worth $147 billion so that the country could make debt repayments to creditors. In exchange for the largest bailout ever assembled, the government announced combined spending cuts and tax increases totaling $40 billion over three years, on top of the tough austerity measures already taken. Greece, however, struggled to meet 2010 targets set by the EU and the IMF, especially after Eurostat - the EU's statistical office - revised upward Greece's deficit and debt numbers for 2009 and 2010. European leaders and the IMF agreed in October 2011 to provide Athens a second bailout package of $169 billion. The second deal however, calls for Greece's creditors to write down a significant portion of their Greek government bond holdings. In exchange for the second loan Greece has promised to introduce an additional $7.8 billion in austerity measures during 2013-15. However, these massive austerity cuts are lengthening Greece's economic recession and depressing tax revenues. Greece's lenders are calling on Athens to step up efforts to increase tax collection, privatize public enterprises, and rein in health spending, and are planning to give Greece more time to shore up its economy and finances. Many investors doubt that Greece can sustain fiscal efforts in the face of a bleak economic outlook, public discontent, and political instability.

Source : CIA

 


Company name            

 

MEDICON HELLAS S.A.

 

 

IDENTIFICATION DETAILS

 

ADDRESS:                               5-7 MELITONA                                             

                                                            15344 GERAKAS                                            

ATTIKI                                                   

GREECE                                                    

TELEPHONE:                            30  2106606000                                           

TELEFAX:                                 30  2106612666                                           

E-MAIL:                                    man@mediconsa.com                                        

WEBSITE:                                 www.mediconsa.com  

 

 

SENIOR COMPANY PERSONNEL

 

Chairman :                                Spyridon Stylianos Dimotsantos

vice-chairman:                           Evangelos Iordanis Baltzoglou

chief executive:                         Spyridon Stylianos Dimotsantos

Deputy Managing Director:        Evangelos Iordanis Baltzoglou

Member:                                   Chryssanthos George Mitropoulos

Dimitrios Stamboulis

John Damianos Prassinos

Dimitrios John Kapetanakis

Theodora Athanasios Mitsiou

 

PRINCIPALS ANTECEDENTS:                                                    

NAME: Spyridon Stylianos Dimotsantos

Also a director of MEDICON COSMETICS S.A., BIOSTAT S.A., MEDICON HELLAS LTD, MEDILAB LTD.

Also a partner in MEDILAB LTD.

 

NAME: Evangelos Iordanis Baltzoglou

Also a director of MEDICON HELLAS LTD, MEDILAB LTD, MEDICON COSMETICS S.A..

Also a partner in MEDILAB LTD.

 

NAME: Spyridon Stylianos Dimotsantos

Also a director of MEDICON COSMETICS S.A., BIOSTAT S.A., MEDICON HELLAS LTD, MEDILAB LTD.

Also a partner in MEDILAB LTD.

 

NAME: Evangelos Iordanis Baltzoglou

Also a director of MEDICON HELLAS LTD, MEDILAB LTD, MEDICON COSMETICS S.A..

Also a partner in MEDILAB LTD.

 

NAME: Chryssanthos George Mitropoulos

Also a director of MEDICON HELLAS LTD, MEDILAB LTD.

Also a partner in MEDILAB LTD.

 

NAME: John Damianos Prassinos

Also a director of MEDICON HELLAS LTD, MEDILAB LTD, MEDICON LTD.

Also a partner in MEDILAB LTD.

 

 NAME: Dimitrios John Kapetanakis

Also a director of FOROCOM S.A..

Also a partner in DYNAMIC FIVE LTD.

 

 

EMPLOYEES

 

EMPLOYS: 74 as at Apr 2, 2013.

 The group employs 97.

The number of employees varies according to needs.

The number of employees peaks to 74.

 

 

PAYMENTS

 

A check against all available information revealed that no late payment incidents against Subject Company exist.

 

 

ASSESSMENT

 

Above Average Risk.

 

 

BANKERS

 

National Bank of Greece S.A., Ag. Paraskevi Branch branch., 8 Iroon Polytechneiou & 2 Giavassi, Agia Paraskevi 15342, Greece.

Telephone: 30 2106080051

 

Emporiki Bank, Themistokleous Branch branch., 4 Themistokleous & El.

Venizelou, Athens 10678, Greece.

Telephone: 30 2103822207

 

Geniki Bank, Halandri Branch branch., 87 And. Papandreou, Halandri 15232, Greece.

Telephone: 30 2106891352

 

EFG EUROBANK ERGASIAS S.A., Ag. Paraskevi Branch branch., 45 Ag. Ioannou, Agia Paraskevi 15342, Greece.

Telephone: 30 2106006600

 

Attica Bank S.A, Ag. Paraskevi Branch branch., 392a Messogeion, Agia Paraskevi 15341, Greece.

Telephone: 30 2106013780

 

Bank of Piraeus S.A., Panormou Branch branch., 70-72 Panormou, Athens 11473, Greece.

Telephone: 30 2106931100

 

T BANK S.A., Kifissia Branch branch., 269 Kifissias Ave & Mitr. Iakovou, Kifissia 14561, Greece.

Telephone: 30 2108080492

 

Hellenic Bank LTD, Holargos Branch branch., 250 Messogeion Ave, Holargos 15561, Greece.

Telephone: 30 2106595900

 

Bank of Cyprus Ltd, Ag. Paraskevi Branch branch., 507 Messogeion Ave, Agia Paraskevi 15343, Greece.

Telephone: 30 2106007528

 

 

FINANCIALS

 

ANY AMOUNTS HEREAFTER ARE IN EURO UNLESS OTHERWISE STATED

 

                                                                                     Fiscal                 Fiscal                Fiscal

                                                                                     Dec 31,2010      Dec 31,2011     Dec 31,2012

 

Turnover                                                                           13,464,413         11,945,399         9,061,751

Pre-Tax Profit                                                                        -239,842        -13,819,764        -1,496,455

Net Worth                                                                         15,433,198           3,462,615          2,874,572

Fixed Assets                                                                       4,752,179           5,968,189          5,823,974

Total Assets                                                                      53,477,617         36,253,949        33,810,521

Current Assets                          `                                       25,034,012         22,432,428        20,234,224

Current Liabilities                                                               25,483,461         21,571,908        30,270,314

Working Capital                                                                     -449,449               860,520       -10,036,090

Long Term Debt                                                                12,560,958         11,219,425              665,635

Financial Assets                                                                23,529,760           7,714,920           7,634,066

Intangibles                                                                              161,666              138,412              118,257

Employees                                                                             109                        92                        89

 

Net Worth and Total Assets are tangible figures shown after the deduction of intangible assets.

 

RATIOS 

 

Dec 31,2010      Dec 31,2011     Dec 31,2012

 

Current Ratio (X)                                                                        0.98                    1.04                   0.67

Solvency Ratio (%)                                                                    246.51                947.01            1,076.19

Fixed Assets/Net Worth (%)                                                        30.79                172.36               202.60

Current Liabs/Net Worth (%)                                                       165.12                623.00            1,053.04

Asset Turnover (%)                                                                      25.18                  32.95                 26.80

Sales / Net Working Cap (X)                                                         -29.96                  13.88                 -0.90

Assets / Sales (%)                                                                        397.18                303.50              373.11

Profit Margin (%)                                                                          -1.78               -115.69               -16.51

S/holders Return (%)                                                                  -1.55               -399.11               -52.06

Return On Assets (%)                                                                 -0.45                 -38.12                 -4.43

Sales / Employees                                                                    123,526.72        129,841.29      101,817.43

Profit / Employees                                                                     -2,200.39       -150,214.83      -16,814.10

 

 

Abstract from individual fiscal Balance Sheet as at Dec 31, 2012

 

 

                                    LIABILITIES                                                                             ASSETS                       

 

Capital                                      6,602,592                                  Land/Buildings               7,959,316

 

Retained Profits                      -11,612,909                                 Plant/Machinery            3,840,465

 

Misc Reserves                          7,884,889                                  Depreciation                   5,975,807

 

Net Worth                                 2,874,572                                  Total Fixed Ass                5,823,974

 

Misc Provisions                           665,635                                  Shares in Group              3,473,515

 

                                                                                                Misc Fin'cl Ass                 4,160,551

                                                                                                Total Fin'cl Ass                 7,634,066

                                                                                                Misc Intangible                    118,257

                                                                                                Total Intangible                   118,257

 

                             CURRENT LIABILITIES:                                                     CURRENT ASSETS:              

 

Trade Creditors                         2,453,361                                   Stock                               2,313,362

Short term Loans                    27,297,715                                    Trade Debtors               14,410,429

Proposed Dividends                       21,578                                 Misc Debtors                   1,671,204

                                                                                                 Cash                               356,917

                                                                                                 Market Securities            1,482,312

TOTAL CURRENT                      30,270,314                                TOTAL CURRENT            20,234,224

TOTAL LIABS & NW                  33,810,521                                TOTAL ASSETS                 33,810,521

 

 

Profit & Loss Account from Jan 1, 2012 to Dec 31, 2012               

Net Sales                                                                                                          9,061,751

Cost of Goods Sold                                                                                          2,180,934

Gross Profit                                                                                                      6,880,817

Misc Operating Charges                                                                                    6,948,768

Misc Operating Income                                                                                         556,137

Net Operating Income                                                                                           488,186

Interest Payable                                                                                                1,984,641

Total Financial Expenses                                                                                   1,984,641

Profit Before Taxes                                                                                           -1,496,455

Income Tax                                                                                                         -802,340

Profit After Tax                                                                                                   -694,115

Net Loss                                                                                                              694,115

Earnings per Share                                                                                                        -0

Previous Year                                                                                                               -2

 

 

LEGAL STATUS AND HISTORY

 

BACKGROUND

Business started Jan 1, 1988.

Subject acquired the business of MEDICON COSMETICS S.A., a Societe anonyme which started in 1998 with effect from Dec 31, 2003.

 

 

LEGAL FORM

 

Societe anonyme registered on Jan 1, 1988 for a period ending Dec 31, 2018.

Registration Number:                             016439

Government Gazette Number:                00079 / 1988

Chamber of Commerce Number:            78664

Tax Registration Number:                       094240321

 

 

Established in Athens (10 Athanassiou Diakou str.), on 18.1.1988. In 1988 (Gov. Gaz. No.: 2447/88) its head office was moved to 10 Vissarionos Str. and in 1989 (Gov. Gaz. No.: 363/89) to 9 Lakonias Str., Gerakas. On 26.9.1995 (Gov. Gaz. No. 5536/95), subject absorbed the firm MEDICON HELLAS LTD, which was established in 1979. On 31.10.97, subject absorbed the firm MEDILAB LTD, which was established in 1983. In 1997 (Gov. Gaz. No: 67/97), subject moved its head office to the above mentioned. On 31/12/2003 (Gov. Gaz. No. 13919/2003) subject absorbed the firm(s) MEDICON COSMETICS S.A.,

Listed in ASE as of: 7,11,2001 

 

Nominal capital is divided into:

4,178,856 shares of 1.58 each and fully paid-up.

 

 

RELATED COMPANIES

 

SUBSIDIARIES

MEDICON INTERNATIONAL HOLDINGS LIMITED Foreign Participants, Nicosia, Cyprus, Cyprus

Year started: 2008.

Subject owns 100% of the capital.

 

HELLENIC INFORMATICS LTD Limited Liability Company, Glyka Nera, Greece

Year started: 1995.

Subject owns 51% of the capital.

 

 

AFFILIATES

 

The following are related through principal(s) and/or financial interest(s):

 

MEDILAB LTD Limited Liability Company, Gerakas, Greece

This is a dormant concern.

Year started: 1983.

This concern is related through common shareholders.

 

MEDICON LTD Limited Liability Company, Glyka Nera, Greece

Year started: 1986.

Subject has a 23.64% share interest.

 

 

SHAREHOLDERS

 

Spyridon Dimotsantos holds 19.15% of the voting capital.

Maria Dimotsantou holds 9.61% of the voting capital.

Maria -Eleni Dimotsantou holds 9.57% of the voting capital.

George Dimotsantos holds 9.57% of the voting capital.

John Prassinos holds 6.99% of the voting capital.

Evangelos Baltzoglou holds 4.59% of the voting capital.

Chryssanthos Mitropoulos holds 3.40% of the voting capital.

Anna Mitropoulou holds 2.99% of the voting capital.

Sotiria Mitropoulou holds 2.99% of the voting capital.

Athanassia Mitropoulou holds 2.99% of the voting capital.

Aikaterini-Elen Baltzoglou holds 2.63% of the voting capital.

George-Konst Baltzoglou holds 2.57% of the voting capital.

Iordanis-Andrea Baltzoglou holds 2.57% of the voting capital.

Damianos Prassinos holds 1.79% of the voting capital.

Eleni Prassinou holds 1.79% of the voting capital.

Paraskevi Prassinou holds 1.79% of the voting capital.

 

 

ACTIVITIES

 

Local Activity Code:                  4646                                          

Local Activity Code Type:          STAKOD                                        

Equivalent to:                            NACE 1                                        

 

"Wholesales drugs, proprietaries, and sundries"

Manufactures pharmaceutical preparations

Representations, imports, production and wholesale trade of reagents, laboratory instruments, cosmetics and medicated products. Technical support. Diagnostic Centre , Subject's customers are public and private

hospitals, diagnostic centers, etc.

 

Subject reportedly acts as agents for:

Beckman Coulter, Germany

Nova Biomedical Corporation, U S A

Siemens Diagnostics, U S A

Cepheid, U S A

Yd, South Korea

 

Subject produces the following brand(s):

MEDICLEAN

MEDICON

MEDICON DIAGNOSTICS

MEDILAB

MEDILYSE

MEDILYZER BT

MEDILYZER F

MEDIRINSE

MEDITERGE

MEDITON

MISS BEAUTE

 

 

IMPORTS

 

Imports 85% from France, Germany, Ireland, South Korea, U S A

Normal importing terms are cash against documents

 

 

EXPORTS

 

Exports 3% to China, Finland, Romania, Slovenia, Spain, U S A

Normal exporting terms are open account

 

 

PROPERTIES

 

Operates from owned workshop, covering approximately 1,127 square metres at heading address.

 

BRANCHES:

Subject has 4 branches/divisions

3 Melitona, 15344, Gerakas, Greece. These are owned office premises.

Size: 896 square metres.

 

7 Melitona, Dimosthenous & Mavrovouniou, 15344, Gerakas, Greece. These are owned warehouse premises. Size: 3737 square metres.

 

34100, Halkida, Greece. These are owned premises. Size: 10000 square metres.

 

66 Chryssostomou, 71306, Irakleio, Greece. These are rented office premises. Size: 30 square metres.

 

 

GENERAL COMMENT

 

Please note that the information provided in the report was obtained from official sources.

No further information available regarding the subject

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.56.10

UK Pound

1

Rs.85.13

Euro

1

Rs.72.80

 

INFORMATION DETAILS

 

Report Prepared by :

SDA

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.